Sen. Bernie Sanders (I-Vt.) opened his first barrage against the pharmaceutical industry as the top lawmaker on the Senate HELP Committee, taking to the Senate floor Wednesday to lambast drug executive compensation as “unacceptable corporate greed.”
The Freedom of Information Act (FOIA) request seeks materials regarding cost considerations, the FDA’s Accelerated Approval Program, and potential harm to.
Medicare says it's considering a cut in enrollee premiums, after officials stuck with an earlier decision to sharply limit coverage for a pricey new Alzheimer's